chr1-219914705-C-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_018713.3(SLC30A10):​c.*744G>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.85 in 152,250 control chromosomes in the GnomAD database, including 55,385 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.85 ( 55384 hom., cov: 32)
Exomes 𝑓: 1.0 ( 1 hom. )

Consequence

SLC30A10
NM_018713.3 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.0350

Publications

18 publications found
Variant links:
Genes affected
SLC30A10 (HGNC:25355): (solute carrier family 30 member 10) This gene is highly expressed in the liver and is inducible by manganese. Its protein product appears to be critical in maintaining manganese levels, and has higher specificity for manganese than zinc. Loss of function mutations appear to result in a pleomorphic phenotype, including dystonia and adult-onset parkinsonism. Alternatively spliced transcript variants have been observed for this gene. [provided by RefSeq, Mar 2012]
SLC30A10 Gene-Disease associations (from GenCC):
  • cirrhosis - dystonia - polycythemia - hypermanganesemia syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, PanelApp Australia, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BP6
Variant 1-219914705-C-A is Benign according to our data. Variant chr1-219914705-C-A is described in ClinVar as Benign. ClinVar VariationId is 295578.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.954 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_018713.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLC30A10
NM_018713.3
MANE Select
c.*744G>T
3_prime_UTR
Exon 4 of 4NP_061183.2
SLC30A10
NM_001376929.1
c.*744G>T
3_prime_UTR
Exon 4 of 4NP_001363858.1A0A8Q3WLF3
SLC30A10
NM_001416004.1
c.*744G>T
3_prime_UTR
Exon 3 of 3NP_001402933.1B3KR19

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLC30A10
ENST00000366926.4
TSL:1 MANE Select
c.*744G>T
3_prime_UTR
Exon 4 of 4ENSP00000355893.4Q6XR72-4
SLC30A10
ENST00000356609.2
TSL:1
n.*1568G>T
non_coding_transcript_exon
Exon 4 of 4ENSP00000349018.2Q6XR72-3
SLC30A10
ENST00000484079.1
TSL:1
n.2020G>T
non_coding_transcript_exon
Exon 2 of 2

Frequencies

GnomAD3 genomes
AF:
0.850
AC:
129280
AN:
152130
Hom.:
55341
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.962
Gnomad AMI
AF:
0.673
Gnomad AMR
AF:
0.832
Gnomad ASJ
AF:
0.767
Gnomad EAS
AF:
0.869
Gnomad SAS
AF:
0.815
Gnomad FIN
AF:
0.825
Gnomad MID
AF:
0.778
Gnomad NFE
AF:
0.798
Gnomad OTH
AF:
0.826
GnomAD4 exome
AF:
1.00
AC:
2
AN:
2
Hom.:
1
Cov.:
0
AC XY:
0
AN XY:
0
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
1.00
AC:
2
AN:
2
Other (OTH)
AC:
0
AN:
0
GnomAD4 genome
AF:
0.850
AC:
129378
AN:
152248
Hom.:
55384
Cov.:
32
AF XY:
0.848
AC XY:
63135
AN XY:
74410
show subpopulations
African (AFR)
AF:
0.962
AC:
39999
AN:
41572
American (AMR)
AF:
0.831
AC:
12720
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.767
AC:
2661
AN:
3470
East Asian (EAS)
AF:
0.869
AC:
4489
AN:
5168
South Asian (SAS)
AF:
0.813
AC:
3928
AN:
4832
European-Finnish (FIN)
AF:
0.825
AC:
8722
AN:
10574
Middle Eastern (MID)
AF:
0.769
AC:
226
AN:
294
European-Non Finnish (NFE)
AF:
0.798
AC:
54275
AN:
68018
Other (OTH)
AF:
0.826
AC:
1747
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
972
1945
2917
3890
4862
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
890
1780
2670
3560
4450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.811
Hom.:
155957
Bravo
AF:
0.855
Asia WGS
AF:
0.862
AC:
2996
AN:
3474

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Hypermanganesemia with dystonia, polycythemia, and cirrhosis (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.94
CADD
Benign
0.38
DANN
Benign
0.32
PhyloP100
0.035

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2275707; hg19: chr1-220088047; API